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Abstract
OBJECTIVE: To evaluate the efficacy, safety,
satisfaction, discomfort and patient preference of
moxa cones of artemisia vulgaris and charcoal
moxa.
METHODS: This comparative study of moxibustion
treatment with Artemisia vulgaris and charcoal
moxa cone stimulating Zhongwan (CV 12) is a
cross-over single-blinded, randomized clinical trial.
A total of 40 healthy subjects (24 males and 16
females) participated in this study. Two subjects
dropped out of the trial. Thirty-eight subjects were
treated with Artemisia vulgaris and charcoal moxa
cones for 30 min in a cross-over design. After
treatment, the patients underwent a 30 minute
waiting period, and then the temperatures at
Tanzhong (CV 17), Zhongwan (CV 12) and
Guanyuan (CV 4) were measured using digital
infrared thermal imaging.
RESULTS: After the use of Artemisia vulgaris moxa,
the patients' body temperatures were slightly
lowered at Tanzhong (CV 17), Zhongwan (CV 12)
and Guanyuan (CV 4), but the changes were not
statistically significant. After the use of charcoal
moxa, the patients' body temperatures were
somewhat increased at Zhongwan (CV 12) and
Guanyuan (CV 4), but the changes were not
statistically significant. After Artemisia vulgaris
moxa use, the body temperature difference
between Zhongwan (CV 12) and Guanyuan (CV 4)
was significantly increased. After charcoal moxa
use, the body temperature difference between
Tanzhong (CV 17) and Zhongwan (CV 12) was
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significantly decreased in males and in the whole
group. This change was caused by the difference in
the moxibustion type and by gender differences.
CONCLUSION: This pilot study found that
moxibustion did not raise the body temperature,
but temperature differences between acupoints
were affected. Further large-scale randomized
controlled trials are needed for the effect of
moxibustion on body temperature.
© 2015 JTCM. All rights reserved.
Key words: Moxibustion; Point CV12 (Zhongwan);
Artemisia; Body temperature; Cross-over studies;
Single-blind method; Randomized controlled trial
INTRODUCTION
Moxibustion is therapeutic procedure that uses
burning material to apply heat to acupoints or areas of
the body surface to treat disease by regulating the
function of meridians / channels and visceral organs.1
By warming the meridians, relieving the obstruction of
collateral vessels, and regulating the Zang-Fu organs,
moxibustion has been used to treat and prevent
diseases for more than 2500 years.2-4
Traditionally, moxibustion has been used to treat
indigestion, fatigue, cold sensation and other disorders
in East and North Asia. Since 2003, an increasing
number of diverse clinical trials for moxibustion have
been conducted.2 In Korea, moxibustion treatment has
been widely used to prevent and treat diseases, and its
use is increasing among Korean medicine pra-
ctitioners.2,3
At present, there are different types of moxibustion
based on the materials and procedures used. Mugwort
leaves (Artemisia vulgaris) are the most commonly used
material in moxibustion; they are purified and
prepared to form a fine, soft moxa floss.
In Korea, many kinds of moxibustion and moxibustion
apparatuses have been developed, and the sale and use
of moxibustion materials are increasing. However, no
studies have compared the use of different types of
moxa cones. The aim of this study is to evaluate the
efficacy and safety of different types of moxa cones on
body temperature.
METHODS
Study design
Trial registration: ClinicalTrials.gov identifier:
NCT01366456. This study was a cross-over design,
single-blinded, randomized, controlled clinical trial
evaluating the efficacy on body temperature and safety
of burning Artemisia vulgaris and charcoal moxa
cones. We chose a single-blind design because
practitioners knew which kind of moxa cone was used,
thus making a double-blind study impossible. To
ensure the quality of this clinical trial, we used an
objective endpoint (digital infrared readings) and
received self-reported information from the subjects.
Inclusion and exclusion criteria
Target samples of patients were recruited from
Semyung University Chungju Hospital, a traditional
Korean medicine hospital. Participants who met all of
the eligibility requirements were eligible for
enrollment. The eligibility criteria were as follows:
males or females aged between 18 and 65 years who
gave their written informed consent to participate and
agreed to comply with the study regulations. Patients
with any of the following conditions were excluded from
the study: any type of thyroid dysfunction, heart disease
(heart failure, angina pectoris, and myocardial infar-
ction), uncontrolled hypertension (SBP > 145 mm Hg
or DBP > 95 mm Hg), impaired hepatic or renal
functions, and diabetes mellitus. Women who were
pregnant, breast feeding or were of reproductive age
and not using proper contraception were also excluded.
Sample size
We had difficulties determining adequate sample size,
as preliminary studies were insufficient. Therefore, we
adopted a pilot study design. This clinical trial was a
pilot study with a cross-over design. A total of 40
subjects were recruited, and each group had 40
subjects.
Patient characteristics
We collected data pertaining to the patients' age, sex,
quality of life, and health. For quality of life and
health, we used the World Health Organization-
Quality of Life (WHO-QOL).
Body temperature measures
We used digital infrared thermal imaging (DITI) to
measure body temperature. We measured body
temperature at Tanzhong (CV 17), Zhongwan (CV 12)
and Guanyuan (CV 4).
Patient satisfaction, discomfort and preference
according to moxa cone type
To determine moxa preference, we asked the patients
whether they preferred the first moxa, the second moxa
or both. We used a numeric rating scale to rate moxa
satisfaction and discomfort.
Moxa cone
Two kinds of moxa cones used that are common in
clinical practice in Korea. The first was a Shingi-gu
(the product's name in Korea) Artemisia vulgaris moxa
cone (registered as number D101389 by Korean Food
and Drug Association; Haitnim, Inc., Incheon, Korea).
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The other was a Sutssuktan charcoal moxa cone
(model number DB250; DONGBANG Medi-care
Acupuncture, Inc., Boryeong, Korea).
Moxa production methods
Artemisia vulgaris moxa cone: artemisia vulgaris is
crushed to a powder, compacted and burned.
Charcoal moxa cone: materials were Carbonized
Artemisia vulgaris, jade, clay, germanium and
bioceramic. The moxa was shaped into a cone and
treated in a special oven to produce a moxa charcoal,
thus eliminating the smoke, tar, and odor associated
with traditional moxa. It was coated with a special
compound of bio-clay, jade, germanium and
bioceramic to enhance its effects. The moxa cone
required approximately 5 min to reach an effective
temperature. Each cone lasts 20 to 25 min. Charcoal
moxa's gentle warmth and far infrared radiation
promotes improved immune system activity.
Moxibustion apparatus: during the intervention, we
placed the moxa cones in the same moxibustion
apparatus to prevent bias by maintaining blinding.
Furthermore, the data analyst was unaware of the
treatment assignment.
Acupoint
Zhongwan (CV 12) is the acupoint for curing cold
sensation in the abdomen, fatigue and indigestion in
Korean medicine clinical practice.
Clinical trial process
We applied one moxa cone per subject for 30 min.
After a 2-day washout period, we applied the other
moxa cone to the subject for 30 min. The subject's
body temperatures were measured 4 times using digital
infrared thermal imaging before and after each
intervention.
The AC group was the intervention group treated with
Artemisia vulgaris first, followed by the charcoal moxa
cone. The CA group was the intervention group
treated with the charcoal moxa cone first, followed by
the Artemisia vulgaris moxa cone. The trial process is
illustrated in (Figure 1).
Randomization
The study subjects were randomly assigned by the
Kyung Hee University Oriental Medicine College
Department of Preventive Medicine. The block size
was 2 or 4. The investigator determined the two
groups randomly using allocation codes.
Safety assessment index
All information, including vital signs, general medical
examinations and adverse events, was recorded for the
safety assessment.
Statistical analyses
For the demographic data and health status, we
calculated the mean, standard deviation, minimum
value, and maximum value of continuous variables and
compared them using paired t-tests. We calculated the
absolute and relative frequency of categorical variables
and analyzed them using the χ2 test or Fisher's exact
test.
If there was a significant difference between the
demographic data or the baseline values of the two
groups, and this difference was considered to be related
to efficacy variables, then we regarded those variables
as confounding factors and used subgroup analysis or
multivariate analysis.
Ethical consideration
This clinical trial was approved by the institutional
review board of Semyung University Chungju Korean
Medical Hospital. Trial registration was completed
(ClinicalTrials.gov identifier: NCT01366456).
RESULTS
General characters
We recruited 40 subjects, and 38 subjects completed
this trial. At baseline, males and females and the AC
group and CA group were not statistically significant
different in terms of any variable (Table 1).
Body temperature changes
The changes in body temperature are presented in
Table 2. In females, the change of body temperature
was statistically significant at Zhongwan (CV 12) and
Guanyuan (CV 4) in the AC group and at Tanzhong
(CV 17) in the CA group. The changes in body
temperature according to the moxibustion type are
presented in Table 3.
Appropriateness of the single-blind design
The appropriateness of the single-blind design is
presented in Table 4.
Completed (n = 20)
Screening (n = 40)
Randomization (n = 40)
AC group (n = 20) CA group (n = 20)
Drop out (n = 2)
Protocol violation (n = 1)
Withdrawal (n = 1)
Completed (n = 18)
Figure 1 Flow chart of study
The AC group, the intervention group treated with
Artemisia vulgaris first, followed by the charcoal moxa cone
two days later; the CA group, the intervention group treated
with the charcoal moxa cone first, followed by the Artemisia
vulgaris moxa cone two days later. AC: Artemisia vulgaris;
CA: Charcoal moxa Artemisia vulgaris.
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Item
Arm 1 / Male [n (%)]
Arm 2 / Female [n (%)]
Age (years)
Experience of Moxa therapy [n (%)]
General Quality of Life (scores)
General Health (scores)
Physical Health (scores)
Psychological health (scores)
Social health (scores)
Environmental Health (scores)
Temperature of CV 17 (℃)
Temperature of CV 12 (℃)
Temperature of CV 4 (℃)
Male
(n = 23)
11 (61.1)
12 (60.0)
23.8±7.2
9 (39.1)
3.6±0.8
3.2±1.0
65.3±14.4
61.3±19.1
66.1±13.6
57.2±13.0
28.9±1.3
28.6±1.3
28.5±1.4
Female
(n = 15)
7 (38.9)
8 (40.0)
29.2±5.5
10 (66.7)
3.6±0.5
3.6±0.5
63.7±11.0
51.7±15.5
65.5±9.2
57.3±14.5
29.3±0.6
28.9±0.5
28.6±0.5
P value
0.944
-
0.865
0.097
0.971
0.718
0.711
0.116
0.883
0.98
0.335
0.461
0.951
AC group
(n = 18)
11 (47.8)
7 (46.7)
30.0±7.4
9 (50.0)
3.6±0.7
3.3±3.2
65.8±14.0
61.3±21.7
69.2±12.6
58.8±16.2
28.8±1.2
28.6±1.2
28.4±1.2
CA group
(n = 20)
12 (52.2)
8 (53.3)
28.0±5.5
10 (50.0)
3.6±0.8
1.0±0.9
63.6±12.4
54.1±14.0
62.9±10.7
55.8±10.5
29.3±1.0
28.9±0.9
28.7±1.0
P value
0.944
-
0.362
1.000
0.691
0.930
0.605
0.229
0.103
0.502
0.210
0.301
0.379
Table 1 General characters of subjects in trials ( xˉ ± s)
Notes: the AC group, the intervention group treated with Artemisia vulgaris first, followed by the charcoal moxa cone two days later; The
CA group, the intervention group treated with the charcoal moxa cone first, followed by the Artemisia vulgaris moxa cone two days later.
AC: Artemisia vulgaris; CA: charcoal moxa Artemisia vulgaris; CV 17: Tanzhong (CV 17); CV 12: Zhongwan (CV 12); CV 4: Guanyuan
(CV 4).
Group
AC
CA
CV 17
CV 12
CV 4
CV 17
CV 12
CV 4
Gender
Male (n = 11)
Female (n = 7)
Total (n = 18)
Male (n = 11)
Female (n = 7)
Total (n = 18)
Male (n = 11)
Female (n = 7)
Total (n = 18)
Male (n = 12)
Female (n = 8)
Total (n = 20)
Male (n = 12)
Female (n = 8)
Total (n = 20)
Male (n = 12)
Female (n = 8)
Total (n = 20)
Artemisia vulgaris Moxa
1st DITI
28.7±1.5
29.1±0.6
28.8±1.2
28.4±1.5
28.8±0.5
28.6±1.2
29.5±2.5
28.6±0.5
28.4±1.2
29.8±2.2
29.7±2.2
29.8±2.2
29.7±2.2
29.3±2.1
28.2±7.0
29.5±2.1
28.8±2.0
29.2±2.0
2nd DITI
29.1±0.7
28.7±0.4
28.9±0.6
29.0±0.7
28.4±0.4
28.8±0.7
29.9±1.9
28.0±0.3
28.3±0.6
29.6±2.6
29.5±2.0
29.5±2.3
29.6±2.5
29.1±2.0
29.4±2.3
29.0±2.4
28.5±2.0
27.5±6.8
P value
0.228
0.086
0.734
0.069
0.025a
0.279
0.721
0.007a
0.821
0.721
0.781
0.641
0.97
0.726
0.842
0.556
0.569
0.411
Charcoal Moxa
3rd DITI
29.8±2.6
29.3±1.5
29.6±2.2
29.6±2.4
28.8±1.4
29.3±2.1
29.5±2.5
28.5±1.6
29.1±2.2
29.2±1.2
29.5±0.6
29.3±1.0
28.9±1.1
29.0±0.4
28.9±0.9
28.8±1.3
28.5±0.6
27.3±6.5
4th DITI
30.2±1.9
29.3±1.0
29.8±1.6
30.0±1.9
28.9±1.2
29.6±1.7
29.9±1.9
28.6±1.6
29.4±1.7
28.9±0.8
28.9±0.6
28.9±0.7
29.0±0.6
28.8±0.6
28.9±0.6
28.5±0.7
28.1±0.6
26.9±6.4
P value
0.525
0.986
0.633
0.352
0.899
0.432
0.483
0.905
0.533
0.420
0.015a
0.054
0.674
0.362
0.979
0.093
0.069
0.121
Notes: the AC group, the intervention group treated with Artemisia vulgaris first, followed by the charcoal moxa cone two days later; the
CA group, the intervention group treated with the charcoal moxa cone first, followed by the Artemisia vulgaris moxa cone two days later.
AC: Artemisia vulgaris; CA: charcoal moxa Artemisia vulgaris. DITI: digital infrared thermal imaging; CV 17: Tanzhong (CV 17); CV 12:
Zhongwan (CV 12); CV 4: Guanyuan (CV 4), a: P < 0.05 and stastically significand.
Table 2 Changes of body temperature before and after moxibustion (℃, xˉ ± s)
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Patients' satisfaction and discomfort with and
preference for specific moxa types
The patients' satisfaction and discomfort with and
preference for the moxa types are presented in Table 5.
Adverse events
Noadverse side effects occurred during the clinical trials.
DISCUSSION
Along with acupuncture and herbal medicine,
moxibustion is a therapeutic tool. Since 2000, one
broad moxibustion study has been conducted.4
Recently, clinical trials have shown the multiple effects
of moxibustion. For example, moxibustion has many
diverse applications, including female obesity
complicated by climacteric syndrome,5 hyperlipidemia,6
herpes zoster,7-8 depression,9 thyroid function,10 knee
osteoarthritis,11 migraine, 12 lung function,13-14 carotid
atherosclerosis,15 cephalic version, 16 breech version, 17-18
delivery,19-20 and etc. Additionally, the safety of
moxibustion has been proven in a clinical trial.21
Studies have examined the mechanism of moxibustion
as related to hormones22, immune system,23,24 aoptosis,25
and anti-aging.26
Item
Artemisia vulgaris Moxa (n = 38)
Charcoal Moxa (n = 38)
Artemisia vulgaris Moxa in male (n = 23)
Charcoal Moxa in male (n = 23)
Artemisia vulgaris Moxa in female (n = 15)
Charcoal Moxa in female (n = 15)
Acupoint
CV 17
CV 17-CV 12a
CV 12
CV 12-CV 4a
CV 4
CV 17
CV 17-CV 12a
CV 12
CV 12-CV 4a
CV 4
CV 17
CV 17-CV 12a
CV 12
CV 12-CV 4a
CV 4
CV 17
CV 17-CV 12a
CV 12
CV 12-CV 4a
CV 4
CV 17
CV 17-CV 12a
CV 12
CV 12-CV 4a
CV 4
CV 17
CV 17-CV 12a
CV 12
CV 12-CV 4a
CV 4
Temperature before intervention
29.07±1.58
0.22±0.47
28.85±1.59
0.19±0.51
28.66±1.51
29.69±1.85
0.39±0.39
29.30±1.76
0.25±0.46
29.05±1.81
28.87±1.52
0.16±0.57
28.72±1.63
0.11±0.58
28.61±1.60
29.87±2.22
0.33±0.43
29.55±2.10
0.13±0.44
29.42±2.08
29.39±1.65
0.33±0.28
29.05±1.57
0.32±0.38
28.73±1.41
29.39±1.08
0.47±0.33
28.92±0.99
0.44±0.42
28.48±1.13
Temperature after intervention
28.90±1.29
0.11±0.31
28.80±1.21
0.54±0.35
28.26±1.15
29.70±1.68
0.13±0.45
29.57±1.71
0.42±0.49
29.15±1.70
28.77±1.14
－0.05±0.27
28.81±1.05
0.53±0.27
28.28±0.98
30.08±1.98
0.05±0.47
30.03±1.96
0.34±0.47
29.69±1.90
29.11±1.51
0.34±0.21
28.77±1.47
0.55±0.44
28.23±1.42
29.11±0.83
0.25±0.38
28.86±0.87
0.53±0.52
28.33±0.86
P value
0.475
0.086
0.825
0.001b
0.124
0.962
0.001b
0.218
0.037b
0.640
0.758
0.051b
0.790
0.006b
0.385
0.465
0.007b
0.084
0.037b
0.380
0.385
0.933
0.293
0.020b
0.130
0.450
0.061
0.868
0.497
0.662
Notes: a: difference of temperature between two acupoints; b: P < 0.05 and statistically significant; CV 17: Tanzhong (CV 17); CV 12:
Zhongwan (CV 12); CV 4: Guanyuan (CV 4).
Table 3 Changes of body temperature by moxa (℃, xˉ ± s)
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With Artemisia vulgaris moxa, the body temperature
difference between Zhongwan (CV 12) and Guanyuan
(CV 4) was significantly higher. With charcoal moxa,
the body temperature difference between Tanzhong
(CV 17) and Zhongwan (CV 12) was significantly
lower among males and for the study population as a
whole. It was considered that this difference was
caused by differences in the moxibustion temperature
and by gender differences.
Artemisia vulgaris and charcoal moxa differ in terms of
smoke, smell, and temperature. In clinical practice,
patients complain about the heat, the smoke and the
smell of Artemisia vulgaris. Consequently, we thought
it would be difficult to maintain even single-blind
conditions. However, the single blinding was well
maintained between genders and groups.
The patient satisfaction with charcoal moxa was
significantly higher and the discomfort was
significantly lower among females. The satisfaction,
discomfort, and preference among difference were
shown in females. It was thought that women were
more sensitive to smell than men. However, the
preference for one moxa type over another was not
statistically significant.
The strengths of this study compared with the previous
studies are as follows: First, to the best of our
knowledge, this is the first single-blind, randomized,
cross-over pilot study to examine moxibustion on
Zhongwan (CV 12). Second, we performed the
interventions at the same time (from 12:00 pm to 1:30
pm). Third, we used digital infrared thermal imaging
at a constant temperature to prevent bias and improve
measurement accuracy.
Our clinical study has three limitations. First, to
prevent burns, we allowed the treatment to move
slightly (2-3 cm) around Zhongwan (CV 12). This
may have changed the subjects' body temperature.
Second, our subjects were healthy people. Thus, body
temperature changes may have been underestimated
because ill people have higher temperatures than
healthy people do. Third, because of limited research
funding, we only did performed one moxibustion per
moxa type per patient. This lack of replication may
have overestimated or underestimated the subjects'
body temperatures. In this pilot study, we found that
moxibustion did not raise the body temperature, but it
affected the temperature difference between acupoints.
Further large-scale randomized controlled trials for the
effect of moxibustion on body temperature are needed.
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